Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platelet-leukocyte interplay during vascular disease
Waltraud C. Schrottmaier, Marion Mußbacher, Manuel Salzmann, et al.
Atherosclerosis (2020) Vol. 307, pp. 109-120
Open Access | Times Cited: 126

Showing 76-100 of 126 citing articles:

Combined use of frontal plane QRS‐T angle and platelet‐to‐lymphocyte ratio in the risk prediction of ischemic cardiomyopathy in STEMI
Tuğçe Çöllüoğlu, Melahat Hicran Aksu, Yeşim Akın, et al.
Annals of Noninvasive Electrocardiology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Association of platelet-to-lymphocyte ratio levels with the risk of cardiac adverse events in people with type 2 diabetes undergoing percutaneous coronary intervention: A large-scale prospective cohort study
Yanjun Song, Zhangyu Lin, Jining He, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 3, pp. 102987-102987
Closed Access | Times Cited: 1
Red ginseng extract inhibits lipopolysaccharide-induced platelet–leukocyte aggregates in mice
Yuan Yee Lee, Sung‐Dae Kim, Jin‐Kyu Park, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 4, pp. 428-434
Open Access | Times Cited: 1
Plasma levels of bactericidal/permeability-increasing protein correlate with systemic inflammation in acute coronary syndrome
Shicheng Yu, Haoxuan Jia, Zheng Li, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32470-e32470
Open Access | Times Cited: 1
Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk
Jiayi Chen, Shuang Liu, Zheng Ruan, et al.
Blood Reviews (2024) Vol. 67, pp. 101220-101220
Closed Access | Times Cited: 1
Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study
Mohammad Ghorbani, Davood Bashash, Mohamad Esmail Gheydari, et al.
Health Science Reports (2024) Vol. 7, Iss. 12
Open Access | Times Cited: 1
Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy
Mengyao Yan, Zhe Wang, Zhiwei Qiu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Combined Antiplatelet Therapy Reduces the Proinflammatory Properties of Activated Platelets
Alexandra C.A. Heinzmann, Daniëlle M. Coenen, Tanja Vajen, et al.
TH Open (2021) Vol. 05, Iss. 04, pp. e533-e542
Open Access | Times Cited: 8
Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury
Christopher Starz, Carmen Härdtner, Maximilian Mauler, et al.
Basic Research in Cardiology (2022) Vol. 117, Iss. 1
Open Access | Times Cited: 6
Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease
Christian Schulte, Luise Pieper, Maike Frye, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 2, pp. 553-557
Open Access | Times Cited: 3
Systemic immune-Inflammation index as a predictor of asymptomatic organ damage in patients with newly diagnosed treatment-naive hypertension
İbrahim Halil İnanç, Cengiz Şabanoğlu
Revista de investigaci�n Cl�nica (2022) Vol. 74, Iss. 5
Open Access | Times Cited: 5
Risk factors and treatment of oxygenator high-pressure excursions during cardiopulmonary bypass
Anders Hjärpe, Anders Jeppsson, Lukas Lannemyr, et al.
Perfusion (2021) Vol. 38, Iss. 1, pp. 156-164
Closed Access | Times Cited: 6
Platelet/Lymphocyte Ratio Predicted Long-Term Prognosis for Acute Upper Extremity Deep Vein Thrombosis from a Retrospective Study
Yang Liu, Hongze Sun, Jianjun Jiang
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 225-234
Open Access | Times Cited: 2
Thrombocytosis in patients with spondyloarthritis: a case–control study
Linan Deng, Pingping Zheng
BMC Musculoskeletal Disorders (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition
Zuzana Paračková, Petra Vrabcová, Irena Zentsová, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 7, pp. 1640-1659
Open Access | Times Cited: 2
Thrombin in the Crossroad Hemostasis and Inflammation
Э. А. Старикова, J. T. Mammedova, О. Ya. Porembskaya
Journal of Evolutionary Biochemistry and Physiology (2023) Vol. 59, Iss. 5, pp. 1710-1739
Closed Access | Times Cited: 2
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates
Francesca Maiorca, Ludovica Lombardi, Ramona Marrapodi, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 8, pp. 102262-102262
Open Access | Times Cited: 2
Thrombin in the Crossroad Hemostasis and Inflammation
Э. А. Старикова, J. T. Mammedova, О. Ya. Porembskaya
Российский физиологический журнал им  И  М  Сеченова (2023) Vol. 109, Iss. 10, pp. 1297-1330
Closed Access | Times Cited: 2
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome
Niema Kazem, Felix Hofer, Lorenz Koller, et al.
European Heart Journal Open (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment
Linlin Cheng, Li Yang, Ziyan Wu, et al.
BMC Immunology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Colchicine for the primary prevention of cardiovascular events
Arturo J Martí-Carvajal, Juan Bautista De Sanctis, Ricardo Hidalgo, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 3
Structure-biological activity relationships of myeloperoxidase to effect on platelet activation
И. В. Горудко, D. V. Grigorieva, Ekaterina V. Shamova, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 728, pp. 109353-109353
Open Access | Times Cited: 3
Platelet-leukocyte interactions: immunoregulatory role and pathophysiological relevance
О. В. Павлов, Sergey V. Chepanov, A. V. Selutin, et al.
Medical Immunology (Russia) (2022) Vol. 24, Iss. 5, pp. 871-888
Open Access | Times Cited: 3
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19
Tanja Eichhorn, René Weiss, Silke Huber, et al.
(2023)
Open Access | Times Cited: 1
Correlation between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Left Ventricular Hypertrophy in Older Patients with Hypertension*
Yingfang Liu, Yan Wang, Meng Ye, et al.
Cardiovascular Innovations and Applications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1

Scroll to top